Also, several oncogenes such as BCL2 (11.5-fold), BRAF (9.8-fold), KRAS (4.9-fold), and SRC (2.8-fold) are significantly stronger expressed in the recurrent chordoma cell line (Additional file 3). This evidence concerns the gene BCL2 and chordoma.